Articles

Home /Articles / FDA Federal Register Notices

No article fund in this category

Top News

Trial Success for Lilly Oral GLP-1
Allovate Illegally Marketing Allerdent, FDA Says
LifeVac Marketing Illegal Airway Device: FDA
FDA Accepts NDA for Once-Daily ADHD Drug
Astellas Pancreatic Cancer Study Misses Endpoint
Leukemia Treatment Data Sets Guidance
Pfizers Tukysa Meets Trial Endpoint
FDA Accepts Rockets Gene Therapy BLA Resubmission

Prev

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Dickinson's FDA Webview is the interactive Web site that watches the U.S. Food and Drug Administration all day long. From the leading publisher of FDA-content business newsletters since 1984, you can monitor regulatory, legal, policy and scientific news affecting all FDA-regulated healthcare products and their marketing activities.